DRISCOLL CHILDRENS HOSPITAL
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $5.1M
- Transactions
- 571
- Companies
- 40
- Average per transaction
- $9,019
Who reported the payments
| Pfizer | $2,425,879 |
| Amgen | $1,125,030 |
| Eli Lilly | $539,973 |
| Merck | $316,757 |
| Jazz Pharmaceuticals Inc. | $234,404 |
| AstraZeneca | $120,228 |
| Travere Therapeutics, Inc. | $98,531 |
| Astrazeneca UK Limited | $70,864 |
| E.r. Squibb & Sons, L.L.C. | $37,646 |
| Janssen Research & Development, LLC | $33,434 |
| Stryker | $25,808 |
| Microgenics Corporation | $24,453 |
| Sanofi US Services Inc. | $20,651 |
| Vertex | $18,409 |
| Incyte Corporation | $18,012 |
| Kls-martin L.p. | $9,500 |
| Sanofi | $4,650 |
| Tandem Diabetes Care, Inc. | $4,500 |
| Insulet Corporation | $3,800 |
| Xeris Pharmaceuticals, Inc. | $2,500 |
| Masimo Corporation | $1,663 |
| Sanofi Pasteur Inc. | $1,550 |
| Olympus America Inc. | $1,000 |
| Sobi, Inc | $1,000 |
| Smith+Nephew | $948 |
| Bristol Myers Squibb | $931 |
| Day One Biopharmaceuticals | $800 |
| Kyowa Kirin, Inc. | $750 |
| Coloplast | $750 |
| Biogen | $750 |
| Sunovion Pharmaceuticals Inc. | $750 |
| Urogen Pharma, Inc. | $738 |
| Scientia Vascular | $595 |
| Vero Biotech Inc. | $416 |
| KARL Storz Endoscopy-america | $360 |
| Electromed, Inc. | $350 |
| Advanced Respiratory, Inc | $350 |
| GE HealthCare | $349 |
| Cochlear Americas | $194 |
| Johnson & Johnson | $128 |